HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In-Kyu Park Selected Research

Hypotension (Low Blood Pressure)

5/2021Kidney-accumulating olmesartan-loaded nanomicelles ameliorate the organ damage in a murine model of Alport syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


In-Kyu Park Research Topics

Disease

79Neoplasms (Cancer)
02/2024 - 10/2005
9Inflammation (Inflammations)
04/2023 - 05/2010
7Breast Neoplasms (Breast Cancer)
02/2024 - 01/2015
6Neoplasm Metastasis (Metastasis)
09/2023 - 01/2013
6Colonic Neoplasms (Colon Cancer)
06/2022 - 02/2011
5Hyperthermia
10/2023 - 10/2015
3Colitis
04/2024 - 07/2012
3Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2023 - 12/2011
3Infections
10/2019 - 04/2017
3Carcinoma (Carcinomatosis)
01/2017 - 05/2010
3Lung Neoplasms (Lung Cancer)
08/2012 - 05/2010
3Atrophic Rhinitis (Ozena)
06/2006 - 03/2004
2Bites and Stings (Sting)
04/2024 - 03/2023
2Hypoxia (Hypoxemia)
09/2023 - 06/2019
2Arthritis (Polyarthritis)
01/2023 - 01/2023
2Peritonitis
01/2023 - 03/2022
2Gouty Arthritis
01/2023 - 01/2023
2Drug-Related Side Effects and Adverse Reactions
01/2023 - 01/2020
2Endotoxemia
03/2022 - 10/2018
2Sepsis (Septicemia)
03/2022 - 10/2018
2Melanoma (Melanoma, Malignant)
11/2020 - 09/2018
2Leukemia
05/2018 - 05/2005
2Stomach Neoplasms (Stomach Cancer)
01/2017 - 01/2013
1Ulcerative Colitis
04/2024

Drug/Important Bio-Agent (IBA)

12VaccinesIBA
02/2023 - 11/2004
10Reactive Oxygen Species (Oxygen Radicals)IBA
04/2024 - 05/2018
7Hyaluronic Acid (Hyaluronan)IBA
04/2024 - 10/2015
7CytokinesIBA
04/2024 - 10/2018
6MicellesIBA
04/2024 - 04/2014
6Small Interfering RNA (siRNA)IBA
03/2023 - 05/2010
6PolyethyleneimineIBA
02/2023 - 11/2005
6Coloring Agents (Dyes)IBA
10/2021 - 01/2015
5Proteins (Proteins, Gene)FDA Link
04/2023 - 04/2014
5AntigensIBA
03/2023 - 09/2018
5Photosensitizing Agents (Photosensitizers)IBA
12/2022 - 01/2020
5PolymersIBA
09/2020 - 04/2018
5ChitosanIBA
04/2018 - 03/2004
41-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2024 - 01/2020
4LipidsIBA
10/2023 - 04/2018
4Peptides (Polypeptides)IBA
02/2023 - 02/2016
4glycol-chitosanIBA
05/2021 - 10/2017
4MicroRNAs (MicroRNA)IBA
05/2017 - 09/2013
4Folic Acid (Vitamin M)FDA LinkGeneric
01/2015 - 05/2010
3InterferonsIBA
04/2024 - 01/2019
3Immune Checkpoint InhibitorsIBA
02/2024 - 11/2020
3Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
09/2023 - 10/2018
3DNA (Deoxyribonucleic Acid)IBA
09/2023 - 11/2005
3PeroxidesIBA
09/2023 - 03/2022
3Liposomes (Liposome)IBA
12/2020 - 05/2010
3CurcuminIBA
08/2020 - 03/2015
32- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA
03/2019 - 02/2018
3Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018 - 01/2015
3Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 05/2005
3DisulfidesIBA
01/2018 - 10/2015
3EnzymesIBA
05/2017 - 07/2012
3Contrast MediaIBA
05/2016 - 03/2013
2LigandsIBA
02/2024 - 01/2018
2manganese oxide (hausmannite)IBA
09/2023 - 04/2022
2Oxygen (Dioxygen)IBA
09/2023 - 01/2023
2CatalaseIBA
09/2023 - 04/2022
2LectinsIBA
04/2023 - 05/2005
2Immunomodulating AgentsIBA
03/2023 - 11/2021
2Protein Subunit VaccinesIBA
02/2023 - 06/2016
2AlbuminsIBA
01/2023 - 01/2018
2Peroxidase (Myeloperoxidase)IBA
01/2023 - 10/2018
2Uric Acid (Urate)IBA
01/2023 - 01/2023
2Immunologic Adjuvants (Immunologic Adjuvant)IBA
12/2022 - 01/2021
2SolutionsIBA
04/2022 - 03/2015
2ferric oxide (iron oxide)IBA
01/2022 - 07/2013
2heptamethine cyanine dyeIBA
10/2021 - 01/2017
2Singlet OxygenIBA
01/2021 - 01/2020
2FlagellinIBA
11/2020 - 02/2016
2GoldIBA
08/2020 - 01/2020
2NanovaccinesIBA
10/2019 - 09/2018
2Interleukin-6 (Interleukin 6)IBA
01/2019 - 10/2018
2RNA (Ribonucleic Acid)IBA
01/2018 - 11/2012
2Nucleic AcidsIBA
05/2017 - 05/2008
2Docetaxel (Taxotere)FDA Link
01/2017 - 01/2013
2LuciferasesIBA
07/2014 - 08/2011
2Galactose (Galactopyranose)FDA LinkGeneric
12/2013 - 05/2005
2Poloxamer (Poloxamer 407)IBA
01/2013 - 02/2011
2Conjugated Linoleic AcidsIBA
01/2013 - 02/2011
2HydrogelsIBA
01/2013 - 02/2011
2Virulence Factors (Pathogenicity Factors)IBA
11/2004 - 03/2004
1cyclic guanosine monophosphate-adenosine monophosphateIBA
04/2024
1RU.521IBA
04/2024
1stearic acid (magnesium stearate)FDA LinkGeneric
04/2024

Therapy/Procedure

39Therapeutics
02/2024 - 05/2010
16Immunotherapy
01/2024 - 01/2015
12Lasers (Laser)
02/2024 - 01/2018
9Photothermal Therapy
02/2024 - 01/2017
9Precision Medicine
10/2023 - 07/2013
9Drug Therapy (Chemotherapy)
12/2022 - 09/2013
5Photochemotherapy (Photodynamic Therapy)
01/2024 - 01/2020
3Radiotherapy
09/2023 - 12/2011
3Microspheres (Microsphere)
01/2016 - 03/2004
2Stents
01/2017 - 05/2012
2Intravenous Injections
05/2016 - 08/2011
2Pneumonectomy (Lung Volume Reduction)
12/2007 - 07/2007
1Induced Hyperthermia (Thermotherapy)
10/2023